What mosaicplasty actually does for a damaged talar dome

If your consultant has raised mosaicplasty as an option, the short answer is this: surgeons take small cylindrical plugs of healthy bone and cartilage from a low-stress area on the side of the knee and press-fit them into the worn or damaged zone on the top of the ankle bone — the talar dome. Think of it as replacing a section of damaged floor tile with a matching piece taken from a less-trafficked corner of the same room. The whole process is completed in a single operation.

The talar dome is a surprisingly common site for osteochondral lesions — areas where both the cartilage surface and the bone immediately beneath it are compromised. These defects typically cause deep aching, episodes of locking, or persistent swelling that does not respond to rest, physiotherapy, or injection support.

Mosaicplasty is not a first-line treatment. Smaller lesions are usually managed with marrow-stimulation techniques such as microfracture, but those procedures produce fibrocartilage — a scar-like repair tissue that is mechanically weaker than the original surface. The plugs transferred in mosaicplasty carry genuine hyaline cartilage, structurally closer to what the joint had before injury. For larger, deeper, or previously treated defects, that distinction matters considerably.

The overarching aim is joint preservation: restoring a durable cartilage surface durable enough to delay, or in some cases avoid, ankle joint replacement.

Which ankle cartilage problems qualify

Most patients who are offered this procedure have a medial osteochondral lesion of the talus — a defect on the inner side of the ankle bone. Prospective multicentre guidance identifies two thresholds that generally push a lesion into mosaicplasty territory: wider than 10 mm² in area, or deeper than 5 mm into the underlying bone. Cystic lesions — classified as Type V, where a cavity has formed beneath the cartilage surface — fall clearly within this range. In published series, defects averaging around 173 mm² have been treated successfully using this technique.

A second qualifying circumstance is a previously attempted repair. Patients who have already undergone microfracture or another procedure that has not held up long-term are appropriate candidates, provided the joint itself is otherwise in reasonable condition.

In reported surgical series, anteromedial lesions — on the inner front of the talar dome — account for roughly 71% of cases, making this the most commonly treated site.

Lateral talar lesions are a different picture. They tend to be smaller, shallower, and more often linked to a specific ankle sprain; prospective guidance positions microfracture — sometimes combined with ligament repair — as the preferred approach there. Mosaicplasty is not routinely indicated for lateral defects.

Outcomes are generally better in younger patients and those whose injury followed an acute sporting event. Conversely, patients with pre-existing widespread ankle osteoarthritis are less likely to achieve good functional scores after the procedure, and a consultant assessment is needed to weigh whether mosaicplasty remains appropriate in that context.

How the operation works in the ankle

Surgeons begin by harvesting cylindrical plugs — typically 6–8 mm in diameter — from the lateral femoral condyle, the low-load outer rim of the knee joint. Each plug contains a column of healthy hyaline cartilage bonded to its underlying subchondral bone. Back at the ankle, matching tunnels are drilled into the damaged talar dome and the plugs are press-fitted into place. The joint then holds them under load, promoting incorporation into the surrounding bone over the weeks that follow.

The trickier part is simply getting there. The talar dome — particularly posteromedial lesions on the inner back of the ankle bone — sits too deep inside the joint to reach safely through an arthroscope alone. To expose the defect properly, surgeons typically need to perform an osteotomy: a controlled, planned cut through the medial malleolus (the bony prominence on the inner ankle). Think of it as temporarily moving a section of bone aside to reach the lesion directly, then fixing it back precisely with cannulated screws before closing.

A refined version of this approach, the triplanar osteotomy, makes cuts in three planes so that the bony window is targeted only to the area overlying the lesion, minimising disruption elsewhere. In a published series of 11 patients, this technique produced no cases of fragment shift or non-union, and patients reached full weight-bearing at a mean of five weeks.

Medial malleolar osteotomy was required in approximately one in four patients across reported series — not every case demands it, as some anteromedial lesions allow sufficient arthroscopic access.

The cannulated screws used to re-fix the osteotomy remain in place while the bone heals, but they do not stay permanently in everyone. Around 25% of patients in one prospective series required a further procedure to remove the hardware — most commonly because of local irritation rather than any failure of healing. It is worth discussing this at the planning stage so that the possibility does not come as a surprise.

One technical refinement worth noting: some surgeons now transplant plugs without formally debriding the recipient bed between them, aiming to fill larger defects without leaving gaps. In a 32-patient series, MRI confirmed sound plug integrity in all participants using this approach, though evidence on whether it changes long-term outcomes remains limited.

What results patients can realistically expect

Pain relief is measurable and meaningful. In a 2025 prospective series of 32 patients, VAS pain scores fell from 6.0 to 1.6 at a mean of 36 months — a statistically significant change that translated into markedly reduced pain at rest and during daily activity. Functional scores follow the same direction: AOFAS ankle scores in that cohort rose from 59 to 85. In a separate large-lesion series (26 patients, average defect 173 mm²), AOFAS improved from 75.0 to 91.5, and all 18 patients who completed a follow-up survey rated their outcome 'good' — in practical terms, improved walking tolerance, reduced reliance on pain relief, and a return to lower-impact activity.

For durability, the strongest available signal comes from a >10-year follow-up study of 19 patients: all transplanted plugs were incorporated on imaging at final review, 89% of patients were satisfied or neutral about the outcome, and 53% had retained their pre-operative osteoarthritis grade — meaning roughly half showed no radiological progression over a decade.

Graft choice matters considerably. A 2021 meta-analysis of 40 studies covering 1,174 procedures found autograft — tissue from the patient's own knee — substantially superior to donor allograft: allograft carried 5.1 times the odds of treatment failure and 7.2 times the odds of revision surgery, alongside lower MOCART and AOFAS scores. Where autograft is used, the evidence base is notably more consistent.

All of this rests on observational series — Level III–IV evidence — and no randomised controlled trial has directly compared ankle mosaicplasty against microfracture or ACI. That limits comparative precision, though the consistency of results across multiple independent series and a large meta-analysis supports well-founded clinical confidence. The single clearest predictor of a sub-optimal result is pre-existing ankle osteoarthritis at the time of surgery — which is why the pre-operative imaging review is as important as the procedure itself.

Donor-site considerations at the knee

The knee is the donor site — and that means patients are, in effect, managing two recovery sites simultaneously, not one. Many people focus entirely on the ankle in the run-up to surgery and are genuinely surprised by post-operative knee soreness that, while usually short-lived, is a real and predictable part of the early recovery picture.

Plugs are harvested from the lateral femoral condyle, the low-load outer rim of the knee, which tolerates limited harvesting reasonably well. For patients requiring a single plug, any knee discomfort typically settles without lasting consequence. The risk profile shifts when two or more plugs are needed: in one large-lesion series of 26 patients, both individuals who developed persistent knee pain had each had two or more plugs harvested. In a separate prospective series of 32 patients, one participant showed a clinically meaningful decline in donor-knee Lysholm score at follow-up. These are minority findings within small cohorts, but they are real, and they are worth naming clearly before surgery rather than explaining afterwards.

A more fundamental limitation is curvature mismatch. The lateral femoral condyle is relatively flat; the talar dome is convex. A cylindrical plug shaped for one geometry cannot sit perfectly flush within the other, so the transplanted cartilage surface will not be fully contiguous with the surrounding native tissue. This is a recognised biological constraint — not a technical error, and not fully resolved by any current modification — and its long-term clinical implications continue to be characterised in the literature.

How mosaicplasty fits the wider ankle cartilage treatment pathway

Mosaicplasty sits in the middle tier of ankle cartilage care — beyond initial symptom management and injection support, but well short of joint replacement. Understanding its position explains why a consultant might recommend it over options that, at first glance, seem simpler or equivalent.

For smaller primary medial lesions, microfracture has historically been the first procedure offered. The evidence now tells a more cautious story: the fibrocartilage that grows into the defect tends to break down within two to three years, and the drilling process can damage the subchondral bone plate in ways that limit future repair options. Mosaicplasty is generally preferred where a lesion is large, deep, cystic, or where a prior procedure has already failed.

Between those two options sits AMIC — matrix-augmented microfracture — a single-stage technique that combines marrow stimulation with a collagen scaffold. It suits mid-sized lesions where full osteochondral plug transfer is not required.

For the largest defects, where harvesting sufficient autograft volume from the knee becomes impractical, two alternatives exist. Cell-based repair — ACI or MACI — involves two separate surgical stages and a period of cell culture, adding complexity and time. Fresh osteochondral allograft (OCA) transfers donor bone and cartilage in one stage for sizeable posttraumatic defects, though a 2021 meta-analysis of 1,174 procedures found autograft consistently superior where volume allows — with allograft carrying 5.1 times the odds of treatment failure.

The clinical decision between these pathways turns most sharply on defect size and depth — precisely what pre-operative MRI and weight-bearing imaging are designed to establish.

1. [1] Osteochondral Lesion of Talus Treated by Mosaicplasty from the Knee as Donor Site. (2025). https://doi.org/10.54361/ljmr.19.2.25 https://doi.org/10.54361/ljmr.19.2.25
2. [2] Osteochondral lesion of the talus: What are we talking about?. (2021). https://doi.org/10.1016/j.otsr.2021.103068 https://doi.org/10.1016/j.otsr.2021.103068
3. [3] Single-Stage All-Arthroscopic Autologous Cancellous Bone Transplantation in Treatment of Cystic Osteochondral Lesion of the Talus. (2024). https://doi.org/10.1016/j.eats.2024.103208 https://doi.org/10.1016/j.eats.2024.103208
4. [4] Outcomes from Osteochondral Autograft Transplant or Mosaicplasty in 26 Patients with Type V Osteochondral Lesions of the Talus. (2021). https://doi.org/10.12659/MSM.930527 https://doi.org/10.12659/MSM.930527
5. [5] A triplanar osteotomy technique in arthroscopy-assisted ankle mosaicplasty. (2020). https://doi.org/10.1177/2309499020905054 https://doi.org/10.1177/2309499020905054
6. [6] Outcome after mosaicplasty for osteochondral lesion of the talus: 19-patients, over 10-year follow-up. (2025). https://doi.org/10.1016/j.fas.2025.11.003 https://doi.org/10.1016/j.fas.2025.11.003
7. [7] Osteochondral Autograft Transplant (Mosaicplasty) Without Debriding the Recipient Site in Osteochondral Lesions of the Talus. (2025). https://doi.org/10.1177/10711007251393253 https://doi.org/10.1177/10711007251393253
8. [8] Knee-to-Ankle Mosaicplasty for the Treatment of Osteochondral Lesions of the Ankle Joint. (2009). https://doi.org/10.1177/0363546509351481 https://doi.org/10.1177/0363546509351481